JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 8, 2006; DOI: 10.1124/jpet.106.108860


0022-3565/06/3192-818-831$20.00
JPET 319:818-831, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.108860v1
319/2/818    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, H.
Right arrow Articles by Pang, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, H.
Right arrow Articles by Pang, K. S.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Increased Estrogen Sulfation of Estradiol 17beta-D-Glucuronide in Metastatic Tumor Rat Livers

Huadong Sun, Lichuan Liu, and K. Sandy Pang

Department of Pharmaceutical Sciences (H.S., L.L., K.S.P.), Leslie Dan Faculty of Pharmacy, and Department of Pharmacology (K.S.P.), Faculty of Medicine, University of Toronto, Toronto, Canada

Changes in the disposition of estradiol 17beta-D-glucuronide (E217G), a substrate of the organic anion-transporting polypeptide family (Oatp) and multidrug resistance-associated protein 2 (Mrp2), were examined in livers of male Wag/Rij rats that were injected with CC531 cells intraportally to induce metastatic tumors (n = 5) or with phosphate-buffered saline for sham-operated controls (n = 4). Multiple indicator dilution, single-pass liver perfusions revealed extremely high influx clearances of [3H]E217G (>190 ml/min) in both groups. In recirculating liver perfusions, [3H]E217G decayed monoexponentially in the reservoir perfusate, and the total (9.19 ± 1.33 versus 8.18 ± 0.94 ml/min) and biliary (4.94 ± 1.07 versus 4.60 ± 0.86 ml/min) clearances were similar in both groups (P > 0.05). The metabolic clearance of E217G was higher in the tumor group (4.60 ± 0.64 versus 3.23 ± 0.23 ml/min, P < 0.05). E23S17G, the 3-sulfate metabolite, whose identity was confirmed by mass spectrometry, appeared only in bile and not perfusate. Liver microsomal incubations of E2335S17G and [3H]estrone sulfate revealed similar sulfatase activities between the tumor and sham livers, albeit the activities were much lower for E2335S17G. Oatp1a1 and Oatp1b2 protein expression in liver membrane fragments was reduced by 42% and 38%, respectively, whereas that of cytosolic estrogen sulfotransferase (Sult1e1) was significantly increased (41%) with tumor (P < 0.05). All of the observations were captured by modeling. From modeling, we showed that reduction of the high influx clearance (546 to 283 ml/min) failed to lower the total clearance of E217G, whereas up-regulation of Sult1e1 increased the E217G sulfation clearance (2.56 to 3.69 ml/min) in livers with metastatic tumors.


Received June 2, 2006; accepted August 7, 2006.

Address correspondence to: Dr. K. Sandy Pang, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, ON M5S 3M2, Canada. E-mail: ks.pang{at}utoronto.ca




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Liu, H. Sun, W. Y. Valji, and K. S. Pang
Transporters, enzymes, and enalapril removal in a rat (CC531-induced) liver metastatic model
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G1078 - G1088.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.